RESALIS THERAPEUTICS
Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
RESALIS THERAPEUTICS
Address:
Torino, Piemonte, Italy
Country:
Italy
Status:
Active
Total Funding:
6 M EUR
Similar Organizations
Alchemab Therapeutics
Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases.
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Finpiemonte
Finpiemonte investment in Seed Round - Resalis Therapeutics
Claris Ventures
Claris Ventures investment in Seed Round - Resalis Therapeutics
Club degli Investitori
Club degli Investitori investment in Seed Round - Resalis Therapeutics